Granules India Limited announced that the United States Food and Drug Administration (USFDA) has concluded a current Good ...

Zydus Lifesciences Limited has announced the appointment of Christoph Stoller as President and Business Unit Head, ...

Venetoclax tablets are indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small ...

The company's flagship brand, Naprosyn, also crossed the Rs 100-crore sales milestone, marking another significant ...

The performance reflects the benefits of the company's strategic transition from an active pharmaceutical ingredients (API) ...

In a major push to advance surgical imaging capabilities in India, medical technology provider Healthware has joined hands ...

The approval of the supplemental Biologics License Application (sBLA) expands ILUMYA’s use beyond moderate-to-severe plaque ...

OneSource Specialty Pharma has received the Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) ...

Through advanced materials science and early-stage collaboration with healthcare innovators, Syensqo is positioning itself as ...

Alivus Life Sciences, formerly Glenmark Life Sciences Limited, delivered a strong financial performance in the second quarter ...

The certification elevates the site’s global regulatory status, opening doors to European and other highly regulated markets ...

In a significant shift in its business mix, the company's Ex-US markets generated Rs 6,963 million in revenue, registering a ...